
Université de Brest
Articles
-
Aug 21, 2023 |
academic.oup.com | Université de Lille |Université de Brest |CHU Besançon |CHU Lille
The efficacy of anti-IL6 receptors such as Tocilizumab (TCZ) was demonstrated in patients with Polymyalgia Rheumatica (PMR) in two recent randomized controlled trials. The objective of this multicentre retrospective study was to assess the efficacy of TCZ in PMR patients requiring GC-sparing treatment, as well as different strategies for TCZ withdrawal. We conducted a multicentre study in French tertiary health care departments for patients with PMR.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →